Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Striatal cholinergic function reflects differences in D-2 dopaminergic receptor activation.

G Forloni1, A Bidzinski, R Fusi

  • 1Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.

Life Sciences
|October 5, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering a multilayered thin-film agarose-based hydrogel to support adipose-derived stromal vascular fraction therapy in spinal cord injury.

International journal of biological macromolecules·2026
Same author

Respiratory complications and sleep disorders in children with chronic kidney disease: A correlation often underestimated.

Paediatric respiratory reviews·2022
Same author

Peripheral inflammation exacerbates α-synuclein toxicity and neuropathology in Parkinson's models.

Neuropathology and applied neurobiology·2020
Same author

Stem cell paracrine effect and delivery strategies for spinal cord injury regeneration.

Journal of controlled release : official journal of the Controlled Release Society·2019
Same author

Review: PrP 106-126 - 25 years after.

Neuropathology and applied neurobiology·2019
Same author

Mesenchymal stem cells encapsulated into biomimetic hydrogel scaffold gradually release CCL2 chemokine in situ preserving cytoarchitecture and promoting functional recovery in spinal cord injury.

Journal of controlled release : official journal of the Controlled Release Society·2018

D-2 receptor activators like bromocriptine and lisuride increase striatal acetylcholine (ACh) levels and inhibit its release. These effects are mediated by dopamine pathways, with varying sensitivity to D-2 receptor antagonists.

Area of Science:

  • Neuropharmacology
  • Dopamine receptor research

Background:

  • Dopaminergic agonists modulate acetylcholine (ACh) release in the striatum.
  • Ergot derivatives like bromocriptine, lisuride, and quinpirole are known D-2 receptor activators.

Purpose of the Study:

  • To investigate the effects of D-2 receptor activators on striatal ACh content and release.
  • To differentiate the mechanisms of action of various ergot derivatives at D-2 dopaminergic receptors.

Main Methods:

  • Administration of ergot derivatives (bromocriptine, lisuride, quinpirole) and apomorphine.
  • Measurement of striatal ACh content and evoked release from brain slices.
  • Antagonism studies using pimozide and L-sulpiride (D-2 receptor antagonists).

Main Results:

Related Experiment Videos

  • Bromocriptine, lisuride, and quinpirole increased striatal ACh content and inhibited ACh release, similar to apomorphine.
  • Pimozide antagonized these effects, confirming dopaminergic mediation.
  • L-sulpiride selectively blocked the effects of apomorphine and quinpirole but not lisuride or bromocriptine, indicating differential D-2 receptor interactions.

Conclusions:

  • Ergot derivatives exhibit distinct interactions with D-2 dopaminergic receptors.
  • Lisuride and bromocriptine's actions on ACh are less sensitive to L-sulpiride antagonism compared to quinpirole and apomorphine.
  • Findings suggest nuanced D-2 receptor pharmacology influencing striatal cholinergic neurotransmission.